Trial Profile
Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2013
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- Acronyms PERGAME
- Sponsors Pfizer
- 25 May 2012 Actual patient number changed 500 to 160 according to ClinicalTrials.gov.
- 29 Sep 2011 New trial record